<DOC>
	<DOCNO>NCT01368627</DOCNO>
	<brief_summary>E-SERIES Registry evaluate procedural clinical outcome Supralimus® SES treatment unselected , high risk patient coronary Artery blockage real world clinical practice .</brief_summary>
	<brief_title>The E-SERIES Registry Supralimus® Coronary Stent Treatment Unselected Patients With Coronary Lesions</brief_title>
	<detailed_description>E-SERIES Registry Prospective , multinational ( Asia , South America Europe ) , non-randomized , post-marketing web-based registry . For Study Up 100 clinical site Asia , South America Europe . Patients `` ALL COMERS '' assign percutaneous coronary intervention present least one angiographically document coronary artery lesion suitable percutaneous treatment Supralimus® SES . All subject provide sign informed consent prior procedure , least one lesion major epicardial vessel major branch ( &gt; 2.25mm ) , suitable percutaneous treatment include stenting procedure Supralimus® SES . There limit regard number lesion and/or study stent use , stenting technique leave operator 's discretion ; however , recommend accord BEST interventional practice accord current guideline . All patient undergo follow-up clinical evaluation 1 , 6 , 12 24 month . Angiographic follow-up perform 6 month subset high risk lesion include bifurcation ( first 100 lesion ) leave main stem ( first 100 lesion ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . CLINICAL INCLUSION CRITERIA : Patients &gt; 18 year , clinical indication elective emergency percutaneous coronary intervention stent implantation least one angiographically document coronary artery lesion ; agreement undergo ALL study protocol followup . 2 . ANGIOGRAPHIC INCLUSION CRITERIA : Diseased coronary vessel least one lesion ≥50 % diameter stenosis visual estimation major epicardial vessel major branch ( &gt; 2.25mm ) anatomy suitable percutaneous treatment Supralimus SES . 1 . CLINICAL EXCLUSION CRITERIA : Known illness life expectancy &lt; 12 month ; impossibility comply protocol followup . 2 . ANGIOGRAPHIC EXCLUSION CRITERIA : Anatomy unsuitable percutaneous treatment implantation Supralimus SES .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Restenosis</keyword>
	<keyword>Stent thrombosis</keyword>
	<keyword>Coronary stent</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Drug Eluting Stents ( DES )</keyword>
</DOC>